¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Propa pH Medicated Acne Cream Maximum Strength"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • acne necrotica
    ±«»ç¿©µå¸§
  • acne necrotica miliaris
    Á¼½Ò±«»ç¿©µå¸§
  • acne papulosa
    ±¸Áø¿©µå¸§, µ¸À½¿©µå¸§, ¼ÚÀ½¿©µå¸§
  • acne rosacea
    ¿©µå¸§Àå¹ÌÁõ
  • acne scar
    ¿©µå¸§ÈäÅÍ
  • acne varioliformis
    µÎâ¸ð¾ç¿©µå¸§
  • acne vulgaris
    º¸Åë¿©µå¸§, ¿©µå¸§
  • cystic acne
    ³¶Æ÷¿©µå¸§, ÁÖ¸Ó´Ï¿©µå¸§
  • drug acne
    ¾à¹°¿©µå¸§
  • furunculoid acne
    Á¾±â¸ð¾ç¿©µå¸§
  • nodulocystic acne
    °áÀý³¶¿©µå¸§
  • occupational acne
    Á÷¾÷¿©µå¸§
  • oil acne
    ±â¸§¿©µå¸§
  • pustular acne
    °í¸§¹°Áý¿©µå¸§, ³óÆ÷¿©µå¸§
  • maximum
    ÃÖ´ë
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • bending strength
    ±ÁÈû¼¼±â, ±¼°î°­µµ
  • bonding strength
    °áÇÕÈû
  • strength duration curve
    °­µµ±â°£°î¼±
  • dynamic strength
    µ¿Àû±Ù·Â
  • ego strength
    ÀÚ¾ÆÈû
  • field strength
    ÀÚÀå¼¼±â
  • fringe magnetic field strength
    ÁÖº¯ÀÚÀå¼¼±â, °¡ÀåÀÚ¸®ÀÚÀå¼¼±â
  • grasp strength
    Áã´ÂÈû
  • ionic strength
    À̿°­µµ
  • low-ionic-strength salt solution
    ÀúÀ̿°­µµ¿°¿ë¾×
  • magnetic field strength
    ÀÚÀå¼¼±â, ÀڱⰭµµ
  • marginal strength
    °æ°è°­µµ
  • muscle strength
    ±ÙÀ°Èû, ±Ù·Â
  • peak gradient strength
    ÃÖ°í°æ»ç¼¼±â, ÃÖ°í±â¿ï±â¼¼±â
  • physical strength
    ü·Â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • acne scrofulosorum
    ¼±º´¼º¿©µå¸§
  • acne varioliformis
    µÎ⼺(Ôãóêàõ) ¿©µå¸§
  • acne venenata
    µ¶¹°¼º ¿©µå¸§
  • acne vulgaris
    º¸Åë¿©µå¸§, ½É»ó¼º ÁÂâ
  • acne vulgaris
    ¿©µå¸§
  • acne, bromine
    Ãë¼Ò¼º ¿©µå¸§, ÁÂâ
  • acne, cystic
    ³¶Æ÷¼º ¿©µå¸§, ÁÂâ
  • acne, excoriated
    Âû»ó¼º ¿©µå¸§, ÁÂâ
  • apocrine acne
    ¾ÆÆ÷Å©¸° ¿©µå¸§
  • furunculoid acne
    Á¾±â¾ç ¿©µå¸§
  • halogen acne
    Çҷΰտ©µå¸§
  • pustular acne
    ³óÆ÷(¼º) ¿©µå¸§
  • pustular acne
    ³óÆ÷(¼º) ¿©µå¸§(ÒÛøÞ(àõ)¡­)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • muscle force =m. strength
    ±Ù ·Â(ÐÉæ³).
  • peak gradient strength
    ÃÖ°í °æ»ç ¼¼±â
  • physical strength
    ü·Â(ô÷æ³).
  • shearing strength
    Àü´Ü°­µµ(¡­Ë­öô).
  • strength
    °­µµ(Ë­öô), Èû, ¼¼±â.
  • strength duration curve
    °­µµ-±â°£°î¼±(Ë­ öôÑ¢ÊàÍØàÊ).
  • strength test
    °­µµ°Ë»ç
  • tearing strength
    Àο­µµ(ìÚæñöô).
  • tensile strength
    ½ÅÀå°­µµ(ãßíåË­öô).
  • tensile strength
    ½ÅÀå°­µµ(ãßíåË­öô)
  • tinting strength
    Âø»ö·Â(ó·ßäæ³).
  • ultimate strength
    ±ØÇѰ­µµ(пùÚË­öô) ¡ìÀç·áÀÇ¡í.
  • wet strength
    ½ÀÀ±µµ(ã¥ëÈöô), ½À°­µµ (ã¥Ë­öô).
  • wound strength
    â»ó°­µµ, â»ó¼¼±â, â»óÈû
  • yield strength
    Ç׺¹°­µµ(ú¢ÜÑË­öô).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
Dmax maximum denaturation; maximum diameter
MAC MacConkey [broth]; major ambulatory category; malignancy-associated changes; maximum allowable conce...
MCP maximum closure pressure; maximum contraction pattern; malanocortin receptor; melphalan, cyclophosph...
MDP manic-depressive psychosis; maximum diastolic potential; maximum digital pulse; methylene diphosphat...
MIP macrophage inflammatory protein; major intrinsic protein; maximum inspiratory pressure; maximum inte...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
WBS Wound breaking strength
U.T.S. ultimate tensile strength
1 RM 1 repetition maximum
RM 1-repetition maximum
FWHM Full width at half maximum
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acne necrotica
    ±«»ç¼º ¿©µå¸§
  • acne neonatorum
    ½Å»ý¾Æ ¿©µå¸§
    ±â¸§Áø ÇǺθ¦ °¡Áø ½Å»ý¾Æ¿¡ ³ªÅ¸³ª´Â Áõ»óÀ¸·Î¼­ ÄÚ, »´, ¾ÕÀ̸¶¿¡ ¿©µå¸§. ±¸Áö, ³óÆ÷°¡ »ý±â´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù.
  • acne papulosa
    ±¸Áø¼º ¿©µå¸§
    º´º¯ÀÌ ±¸Áø¼ºÀÎ ½É»ó¼º ÁÂâ.
  • acne punctata
    Á¡»ó ¿©µå¸§
  • acne rosacea
    µþ±âÄÚ, ÁÖ»çºñ, Áֻ缺 ÁÂâ, Áֻ缺 ¿©µå¸§
  • acne scorbutica
    ±«Ç÷º´¼º ÁÂâ ¿©µå¸§
    ±«Ç÷º´¿¡¼­ ¹ß»ýÇÏ´Â ±¸Áø¼º ¹ßÁø.
  • acne sycosiformis
    ¸ð⼺ ¿©µå¸§
  • acne urticata
    ´ã¸¶Áø¾ç ÁÂâ ¿©µå¸§
    ±¸Áø¼º ÁÂâ°ú À¯»çÇÑ ºÎÁ¾¼º ÆØÁøÀ» Ư¡À¸·Î ÇÏ´Â ¿©µå¸§ ¸ð¾çÀÇ ¹ßÁø.
  • acne venenata
    µ¶¹°¼º ¿©µå¸§
    °¢Á¾ È­Àåǰ ¹× ¸Ó¸´±â¸§ µî¿¡ »ç¿ëµÇ´Â ¿©·¯ È­Çй°Áú ±×¸®°í ¸¹Àº ±â¸§, Ÿ¸£, ¿Î½º, ¿°¼Òȭźȭ¼ö¼Ò µîÀ» Æ÷ÇÔÇÑ °ø¾÷¿ë È­Çй°Áú µî ¿©·¯ Á¾·ùÀÇ ÁÂâ À¯¹ß¼º È­Çй°Áú°ú Á¢ÃËÇÔÀ¸·Î½á ¹ß»ýÇÑ ¿©µå¸§.
  • bromine acne
    Ãë¼Ò¼º ¿©µå¸§, Ãë¼Ò ¿©µå¸§
  • drug acne
    ¾à¹°¼º ¿©µå¸§
  • nodulocystic acne
    °áÁ¤³¶¼º ¿©µå¸§
  • occupational acne
    Á÷¾÷¼º ¿©µå¸§
  • pustular acne
    ³óÆ÷ ¿©µå¸§
  • tar acne
    Ÿ¸£ ¿©µå¸§
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
yield strength The amount of stress at which a permanent (plastic) deformation in a component becomes measurable (usually taken as 0.2% permanent strain).
(05 Mar 2000)
ultimate strength The maximum stress achieved prior to failure of a component on a single application of the load.
(05 Mar 2000)
fatigue strength The stress level below which a particular component will survive an indefinite number of load cycles (typically about 50% of the ultimate strength of the component).
(05 Mar 2000)
acne <dermatology> An inflammatory disease of the pilosebaceous unit, the specific type usually being indicated by a modifying term, frequently used alone to designate common acne or acne vulgaris.
Origin: possibly Gr. Akm = a point or achn = chaff
(15 Nov 1997)
acne albida Acne caused by milia.
(05 Mar 2000)
acne artificialis Acne produced by external irritants, such as tar (chloracne), or drugs internally administered, such as iodides or bromides.
Synonym: acne venenata.
(05 Mar 2000)
acne bacillus A bacteria isolated from normal skin, intestinal contents, wounds, blood, pus, and soft tissue abscesses. It is a common contaminant of clinical specimens, presumably from the skin of patients or attendants.
(12 Dec 1998)
acne cachecticorum Acne occurring in persons who have a debilitating constitutional disease; characterised by large, soft, purulent, ulcerative, cystic, and scarred lesions.
(05 Mar 2000)
acne ciliaris Follicular papules and pustules on the free edges of the eyelids.
(05 Mar 2000)
acne conglobata Severe cystic acne, characterised by cystic lesion, abscesses, communicating sinuses, and thickened, nodular scars; usually sparing the face.
(05 Mar 2000)
acne cosmetica Low-grade, non-inflammatory acne lesions from repeated application of comedogenic agents in cosmetics.
(05 Mar 2000)
acne decalvans A papular or pustular inflammation of the hair follicles of the scalp seen mostly in men, resulting in scarring and loss of hair in the affected area.
Synonym: acne decalvans, alopecia follicularis.
(05 Mar 2000)
acne erythematosa acne rosacea
acne frontalis A pyogenic infection involving follicles occurring chiefly on the forehead and temples; involution of the umbilicated and crusting lesions is followed by scar formation.
Synonym: acne frontalis, acne necrotica.
(05 Mar 2000)
acne fulminans Severe scarring acne in teenaged males, which may be associated with fever, polyarthralgia, crusted ulcerative lesions, weight loss, and anaemia.
Origin: fulmen, fulminis, thunder, lightning
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • dairy cream
    (°¡°øÇÑ °ÍÀÌ ¾Æ´Ñ)³«³óÀåÁ¦ ¿ìÀ¯
  • double cream
    (¿µ)³óµµ ³ôÀº Å©¸²
  • egg cream
    (¹Ì)¿ìÀ¯;Çâ·á;½Ã·´;¼Ò´Ù¸¦ ¼¯Àº À½·á
  • foundation cream
    ¹ØÈ­Àå Å©¸²
  • ice cream
    ¾ÆÀ̽ºÅ©¸²;°áÁ¤²ÃÀÇ ¸¶¾à;¾ÆÆí
  • shaving cream
    ¸éµµ¿ë Å©¸²
  • sour cream
    »þ¿ö Å©¸²;»çÆÐÀ¯
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á